• The Center for Regenerative Medicine is on track towards becoming a center for innovation and stem cell research.
• MakatiMed is the only hospital in the Philippines to receive a DOST grant for a research on umbilical cord-derived stem cells

The Department of Science and Technology (DOST) awarded a P16.4 million grant to Makati Medical Center’s team of doctors and scientists for a study on the use of stem cells as treatment to wounds caused by diabetes. This makes MakatiMed the only hospital in the Philippines to receive a DOST grant for a research on umbilical cord-derived stem cells.

The proposed study, “Evaluation of the Safety and Efficacy of Intramuscular Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells for Diabetic Foot Ulceration”, received the funding from DOST’s Research and Development Management Division of the Philippine Council for Health Research and Development.

The research aims to examine how stem cells from umbilical cord tissues, which are normally discarded after giving birth, can potentially accelerate the wound healing process of patients suffering from the complications of diabetes. The study also projects that using Human Umbilical Cord Mesenchymal stem cells (hUC-MSC) will reduce the need for invasive and painful cell extraction procedures such as bone marrow aspiration and adipose tissue liposuction, thus may cut the high cost associated with generating cell-based treatments.

“We at MakatiMed always aim to give hope to our patients through our services,” says Jose Maria C. Avila, MD, the study’s principal investigator and co-director of MakatiMed’s Center for Regenerative Medicine. “Receiving the support of DOST is a great boost to our cause and we hope that this will pave the way for more innovative cellular treatments.”

Also part of the research team are co-investigators Victor L. Gisbert, MD; May H. Ortiz-Sison, MD; R.J. Gerard J. Panlilio, MD; Teresita E. Dumagay, MD; and Jayson S. Santiago (Junior Scientist); as well as Rodmar C. Pulido (Project Consultant); Benjamin Maligalig (Project Statistician), Kimberly Joy R. Sermon, RMT, MBA-H (Project Manager), and Christian Carl B. Camacho, RPh (Project Monitor).

For more information, please contact MakatiMed Center for Regenerative Medicine at +632.8888 999 local 3614, email [email protected] and [email protected], or visit www.makatimed.net.ph.

• Makati Medical Center celebrates its 50th Anniversary this year
• MakatiMed has partnered with UC Davis Comprehensive Cancer Center (UCDCCC) in a bid to boost cancer care in the Philippines
• UCDCCC, which was designated as a comprehensive cancer center by the US National Cancer Institute, offers the most advanced methods for the diagnosis, prevention, and treatment of cancers and blood disorders

As Makati Medical Center celebrates its 50th Anniversary this year, the premiere hospital continues to drive advancement in medical care in the country by forging a partnership with one of the leading cancer centers in the United States.

MakatiMed has partnered with UC Davis Comprehensive Cancer Center (UCDCCC) in a bid to boost cancer care in the Philippines. The agreement with the University of California, Davis-affiliated medical center includes the development of an international Cancer Care Network, a cancer registry in MakatiMed, training programs for cancer care, a second opinion program, and on-site clinical rotation from various subspecialties in oncology.

Inpatient and outpatient procedures will be evaluated to enhance clinical workflows. The two hospitals will also share telemedicine programs and potentially collaborate in clinical trials, research studies, seminars, and multi-disciplinary teleconferences.

UCDCCC, which was designated as a comprehensive cancer center by the US National Cancer Institute, offers the most advanced methods for the diagnosis, prevention, and treatment of cancers and blood disorders.

“We want to introduce a collaborative approach in cancer care to offer the ideal treatments to our patients,” says Maria Corazon C. Consunji, MD, MakatiMed President and CEO. “This partnership will help MakatiMed achieve the best patient outcomes by embracing the advancements in oncology.”

Dr. Consunji inked the contract with Primo N. Lara, Jr., MD, UCDCCC Director. Also present in the contract signing were UCDCCC’s Gina Dayton, Chief Administrative Officer and Associate Director for Administration, and Kristin Jones, Director for Oncology Services.

For more information, please contact MakatiMed On-Call at +632.8888 999, email [email protected], or visit www.makatimed.net.ph.

• MakatiMed treats moms-to-be with free pregnancy forum
• Makati Medical Center invites parents and parents-to-be to a series of lay forums titled “Pregnancy & Beyond” for free
• MakatiMed’s Department of Obstetrics and Gynecology has been offering this series of lay forums with the Department of Pediatrics since 2010

MakatiMed offers free pregnancy forum for moms-to-be on May 18. Top hospital in the Philippines Makati Medical Center (MakatiMed) invites parents and parents-to-be to a free series of lay forums titled, “Pregnancy & Beyond.”

On May 18, participants can learn about Postpartum Blues, Immunization, and Motherhood for Millennial Moms at the 8th Floor Auditorium Tower 2, Makati Medical Center. Interested moms-to-be can contact 8888 9999 locals 3757 for inquiries and other details.

The first leg of the forum series wraps up on June 22, with the second leg starting by July 20. MakatiMed’s Department of Obstetrics and Gynecology has been offering this series of lay forums with the Department of Pediatrics since 2010 to promote pre- and postnatal care, safe infant care practices, breastfeeding and pediatric development.

Aside from learning from the experts and a chance to socialize with other parents-to-be, attendees are treated to giveaways, product discounts, raffle prizes, and a hefty lunch.

For more information or further inquiries, please contact MakatiMed On-Call through 8888 9999 locals 3757 or 3784, email [email protected], or visit www.makatimed.net.ph.